Search clinical trials for: THC (delta-9 tetrahydrocannabinol), d-amphetamine, oral THC

Total 59 results

Johns Hopkins University
Substance Abuse and Mental Health Services Administration (SAMHSA)

Recruiting

Comparative Pharmacokinetic and Pharmacodynamic Effects of Delta-8 and Delta-9 THC

Behavioral Pharmacology of Cannabis

United States
University of California, San Diego

Recruiting

Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV (CAMI)

HIV | Cannabis | Microbiome | THC | Neuroinflammatory Response | Neuroinflammatory Disease

United States
Wayne State University
National Institute on Drug Abuse (NIDA)

Completed

Marijuana Drug Discrimination and Self-Administration (DDC)

Marijuana Abuse

United States
University of Utah

Recruiting

Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC)

Chronic Pain, Widespread

United States
University of California, San Diego

Enrolling by invitation

Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment

Migraine | Cannabis | THC

United States
University Hospital Inselspital, Berne

Terminated

Does Intravenous Cannabis Reduce Postoperative Nausea and Vomiting (PONV)? (THC)

Nausea | Vomiting

Switzerland
Wageningen University

Completed

The Role of the Endocannabinoid System in Sweet Taste Intensity and Liking (Sweed)

Sensory Science

Netherlands
Jazz Pharmaceuticals

Completed

GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes

Diabetes Mellitus, Type 2 | Dyslipidemias

United Kingdom
Yale University

Active, not recruiting

Probing the Cannabinoid System in Individuals With a Family History of Psychosis

Schizophrenia | Psychosis | Cannabis Use | THC | Marijuana

United States
Radboud University Medical Center
Health Valley, Netherlands

Completed

Delta-THC in Dementia

Pain | Dementia | Vascular Dementia | Behavioural Disturbances | Alzheimer's Dementia

Netherlands
Yale University

Terminated

Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder (THC-BD)

Bipolar Disorder | Healthy Controls | Delta-9-Tetrahydroncannabinol

United States
University of California, San Diego
Migraine Research Foundation

Completed

Efficacy of Inhaled Cannabis for Acute Migraine Treatment

Migraine | Cannabis | CBD | THC

United States
University of Chicago

Completed

Individual Differences in the Response to Drugs (TDS)

Healthy
UMC Utrecht
Leiden University Medical Center; Center for Human Drug Research; TI Pharma

Completed

Investigating the Acute Effects of THC on Functional Brain Systems (FIX)

Magnetic Resonance Imaging | Memory | Reward | Tetrahydrocannabinol | Endocannabinoids

Netherlands
University College, London
Medical Research Council; Invicro

Completed

Do Adolescents and Adults Differ in Their Acute Response to Cannabis? (CannTeenA)

Cannabis | Cannabis Dependence | Cannabis Use | CBD | Adolescent Development | THC | Marijuana | Cannabis Intoxication

United Kingdom
Yale University

Recruiting

Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II (THC-Gender-II)

Cannabis

United States
Johns Hopkins University
Substance Abuse and Mental Health Services Administration (SAMHSA)

Not yet recruiting

Delta-8-THC vs. Delta-9-THC on Simulated Driving Performance

Cannabis

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Age-dependent Effects of Smoked and Oral Delta-9-THC (SAGE)

Pain | Abuse, Drug | Intoxication; Cannabinoids
University of Wisconsin, Madison

Not yet recruiting

High Confusion: Cannabis & Driving

Impairment, Cognitive | Impairment of Attention | Impairment, Psychomotor
City of Hope Medical Center
National Cancer Institute (NCI)

Not yet recruiting

Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

Breast Carcinoma | Chemotherapy-Induced Peripheral Neuropathy | Colon Carcinoma

United States
Yale University

Recruiting

Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans (THC-Gender)

Cannabis

United States
Fundacion para la Investigacion Biomedica del Hospital...
Jazz Pharmaceuticals

Completed

Neuroprotection by Cannabinoids in Huntington's Disease

Huntington's Disease

Spain
Radboud University Medical Center

Completed

Safety and Tolerability of Namisol in the Elderly (THC)

Drug Safety

Netherlands
Yale University

Completed

Cannabinoid Modulation of Pain

Pain

United States
Yale University
Brain & Behavior Research Foundation

Completed

THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis

Cannabis | Ketamine

United States
Wayne State University

Not yet recruiting

Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery (CAPER)

PTSD | Post Traumatic Stress Disorder

United States
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Unknown

Intact Liver Innervation and Glucose and Glucagon-like Peptide-1 (GLP-1) Induced Insulin Secretion

Liver Transplantation

Denmark
Yale University
National Institute on Drug Abuse (NIDA)

Recruiting

In Vivo Study of THC-induced Immune-genome Changes at Single Cell Solution in HIV-infected Humans

HIV Infections | Healthy

United States
Yale University

Completed

Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone (THC-Preg)

Healthy

United States
King's College London

Completed

Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Study (INTEGRATE)

Schizophrenia | Cannabis Use

United Kingdom
Yale University

Active, not recruiting

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I (THC-ETOH-I)

Cannabis | Alcohol Effect | Driving Under the Influence of Alcohol and Other Drugs

United States
Yale University

Not yet recruiting

Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans

Schizophrenia | Cannabis Use Disorder
Yale University

Completed

The Effects of ∆-9-THC and Naloxone in Humans

Healthy

United States
Yale University

Completed

The Effects of Cannabidiol and ∆-9-THC in Humans

Healthy

United States
University of California, San Diego
Center for Medicinal Cannabis Research; Tilray; International Essential Tremor...

Completed

Trial of Cannabis for Essential Tremor

Essential Tremor

United States
Yale University

Active, not recruiting

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition (THC-ETOH)

Cannabis | Alcohol Effect | Driving Under the Influence of Alcohol and Other Drugs

United States
Yale University

Terminated

N-acetylcysteine Effects on Tetrahydrocannabinol

Healthy

United States
Boston University Charles River Campus
National Institute on Drug Abuse (NIDA)

Withdrawn

Multimodal Cue Exposure Therapy for Smoking Cessation

Smoking Cessation
Memorial Sloan Kettering Cancer Center

Completed

Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation

Multiple Myeloma

United States
Kafrelsheikh University
Ministry of Health, Saudi Arabia

Not yet recruiting

Utilizing the Crosstalk Among Chicoric Acid, 13-Cis Retinoic Acid(Aerosolized), Minocycline and Vitamin D as a Potent Quadrate Therapy for Treating Patients With Multidrug-resistant TB and Patient With Both Multidrug-resistant TB and COVID-19

Tuberculosis

Egypt, Saudi Arabia
Umm Al-Qura University

Completed

Alter-G Training on Gait and Balance in Diabetic Neuropathy Patients

Diabetic Peripheral Neuropathy

Saudi Arabia
National Cancer Institute (NCI)
Children's Oncology Group

Completed

Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Untreated Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts | High Risk Myelodysplastic Syndrome | de Novo Myelodysplastic Syndrome | Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 | Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 | Acute Myeloid... and other conditions

United States
Stanford University

Completed

Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases

Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Terminated

Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia

United States
National Cancer Institute (NCI)

Not yet recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

B Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage
Northwestern University
National Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.

Active, not recruiting

Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma

Diffuse Large B-Cell Lymphoma | Plasmablastic Lymphoma | B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma | Adult Burkitt Lymphoma | MYC Gene Mutation

United States
Children's Oncology Group
National Cancer Institute (NCI); EsPhALL Network/ BFM Study Group

Recruiting

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | T Acute Lymphoblastic Leukemia | Mixed Phenotype Acute Leukemia

United States, Canada, Puerto Rico, Australia, Finland, New Zealand, Saudi Arabia, Germany, Austria, Belgium, Chile, Czechia, France, Italy, Netherlands, Sweden, Switzerland, Hong Kong, Israel
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma

Metastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7

United States
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia | Acute Undifferentiated Leukemia | Childhood T Acute Lymphoblastic Leukemia

United States, Canada, Australia, New Zealand

Search clinical trials for: THC (delta-9 tetrahydrocannabinol), d-amphetamine, oral THC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations